About the Journal
On this page: Aims & scope, Journal policies, Disclaimer
Journal of Applied Pharmaceutical Science (JAPS) is a monthly open-access journal dedicated to various disciplines of pharmaceutical and allied sciences. JAPS publishes manuscripts (Original research and review articles Mini-reviews, Short communication) on original work, either experimental or theoretical in the following areas;
- Pharmaceutics & Biopharmaceutics
- Novel & Targeted Drug Delivery
- Nanotechnology & Nanomedicine
- Pharmaceutical Chemistry
- Pharmacognosy & Ethnobotany
- Pharmacology & Toxicology
- Pharmaceutical Biotechnology & Microbiology
- Pharmacy practice & Hospital Pharmacy
- Natural Product Research
- Drug Regulatory Affairs
- Case Study & Full clinical trials
- Biomaterials & Bioactive polymers
- Analytical Chemistry
- Physical Pharmacy
- Open Access Policy
- Peer-review Policy
- Waiver Policy
- Copyright policies
- Author Self-Archiving policies
- Publication ethics and malpractice statement
- Plagiarism Policy
- CrossMark Policy
- Digital Preservation
- Retraction policy
- Preprints policy
- Conflicts of Interest
- Complaints and appeals
In order to ensure the maximum exposure of JAPS contents, we adopted the open access policy, meaning that;
- All the articles published in JAPS are made freely accessible online immediately after publication in an easily readable format, without any subscription or registration barrier.
- All the published articles are licensed under a Creative Commons License, full details of which can be found here.
- Articles can be shared and adapted, provided the attribution for the work is given.
- The journal also allows the authors to self-archive the final accepted version of the articles on any OAI-compliant institutional/subject-based repository.
All the manuscripts submitted to JAPS will be subjected to the double-blinded peer-review process;
The manuscript will be reviewed by three suitable experts in the respective subject area. The reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
Editor-In-Chief will make the final decision, based on the reviewer’s comments.
EIC can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
In case, authors challenge the editor's negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
Note: Journal of Applied Pharmaceutical Science is a member of the World Association of Medical Editors. Please click here for more details about peer review and editorial policies.
JAPS may grant the partial/full waiver in article processing charges to the authors who are unable to pay the APCs due to financial restrictions. Only the authors from low-income countries can apply for the waiver. Please send your waiver requests to firstname.lastname@example.org with complete details.
All the articles published in JAPS are distributed under a creative commons attribution 4.0 International license (read detailed license information here). The journal allows the author(s) to hold the copyright of their work.
Author Self-Archiving Policy
JAPS is a RoMEO green journal. The journal allows the authors to self-archive pre-print, post-print, and publisher's version of the articles in any OAI-compliant repository.
The authors should ensure the originality of their contents while preparing a manuscript draft. In case the authors have used the work and/or words of others this must be appropriately cited or quoted. All the articles submitted to JAPS shall be screened for plagiarism using iThenticate (online plagiarism detection software). In case, plagiarism is detected during the review/editorial process, such manuscript(s) will be rejected immediately. If the plagiarism is proven after publication, such manuscript(s) will be retracted from the journal and an appropriate announcement will be placed in this regard. We can also consider appropriate action against authors depending upon the seriousness of the case. It includes;
Debarring the authors from publication in the future.
We can bring such instants in notice of author's funding agencies, author's institutes (where they work) and to the original authors whose work has been plagiarized.
COPE flow charts (please follow the below link) shall also be considered while dealing with plagiarism complaints.
JAPS follow the COPE Retraction Guidelines. (Link:https://publicationethics.org/files/cope-retraction-guidelines-v2.pdf)
All the contents published in JAPS are archived in Portico (an E-Journal Preservation Service), which provides permanent digital archiving for scholarly journals.
Preprints are defined as an author’s version of a research manuscript prior to formal peer review at a journal, which is deposited on a public server. Journal encourages posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites. Preprints may be posted at any time during the peer-review process. Posting of preprints is not considered prior to publication and will not affect consideration at this journal.
Authors should not assign copyright during the preprint process; authors should retain the copyright of their work when posting to a preprint server. Journal will consider for publication submissions that have previously been assigned CC-BY (-NC/-NC-ND) as preprints.
Authors should disclose details of preprint posting, including DOI and licensing terms, upon submission of the manuscript to this journal. Once the preprint is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.
Conflicts of Interest
A conflict of interest defined as any relationship authors, reviewers or editors have, which interferes with the full and objective presentation, peer review, editorial decision-making, or publication of a manuscript. Conflicts of interest can be financial or non-financial, professional or personal, and can arise in relation to an organization or an individual.
When authors submit a manuscript of any type or format they are responsible for disclosing all relationships and activities that might bias or be seen to bias their work (e.g. employment, consulting fees, research contracts, stock ownership, patent licenses, honoraria, advisory affiliations, etc.). JAPS is committed to following ICMJE recommendation on “Author Responsibilities—Conflicts of Interest” in authors’ conflict of interest issues. The ICMJE has developed a Disclosure Form to facilitate and standardize authors’ disclosures, please click this link to download the ICMJE COI form. Authors are required to upload the duly filled and signed form under the additional files section, during manuscript submission. They can also send it by email to email@example.com. Please follow the link to read the detailed ICMJE recommendations for disclosure of financial and non-financial relationships and activities, and conflicts of interest.
Reviewers must disclose to journal editors any relationships or an activity that could bias their opinions of the manuscript and should recuse them from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests. Please use the review form provided at your reviewer login area to disclose the conflicts of interest.
Editors and Journal Staff
JAPS editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain. When editors submit their own work to this journal, a colleague in the editorial office should manage the manuscript and the editor/author should recuse himself or herself from discussion and decisions about it.
Note: These policies are based upon the ICMJE recommendations.
You may find the following useful resources to refer to for more information on Conflict of Interest policies, existing codes of practices and more general good practice in relation to journal publication ethics:
- View the Guidelines published on good publication and the Code of Conduct by the Committee of Publication Ethics (COPE).
- View the guidelines published by the International Committee of Medical Journal Editors (ICMJE).
Complaints and appeals
Authors & readers can submit their complaints/appeal to the editor or the publisher of the journal through email firstname.lastname@example.org or through the complaint form provided on the contact us page [Link]. All the complaints will assign a unique complaint number by the publisher. Authors/readers can use complaint numbers for further follow-up.
If you do not receive a response to your complaint within 48 hrs or if you are not satisfied with the response please write to associate editor email@example.com or chief editor firstname.lastname@example.org. Please mention your unique comlpaint number in follow-up emails.
The author(s) of each article appearing in this Journal is/are solely responsible for the content thereof; neither the Journal of Applied Pharmaceutical Science nor its editors or publisher nor anyone else involved in creating, producing, or distribution assumes any liability or responsibility for the accuracy, completeness, correctness or usefulness of any information provided in the Journal, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of the Journal of Applied Pharmaceutical Science. The journal remains neutral with regards to the jurisdictional claims in published institutional affiliations.